{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:06:06Z","timestamp":1790730366293,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-025-03590-7","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T05:05:54Z","timestamp":1749704754000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Netarsudil v\/s Ripasudil: The battle of supremacy between two ROCKS-I (rho kinase inhibitors)"],"prefix":"10.1007","volume":"45","author":[{"given":"Riddhima","family":"Juneja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taskin","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishnu Swarup","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niharika","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,12]]},"reference":[{"issue":"11","key":"3590_CR1","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"Y-C Tham","year":"2014","unstructured":"Tham Y-C, Li X, Wong TY, Quigley HA, Aung T, Cheng C-Y (2014) Global prevalence of glaucoma and projections of glaucoma burden through 2040. Ophthalmology 121(11):2081\u20132090. https:\/\/doi.org\/10.1016\/j.ophtha.2014.05.013","journal-title":"Ophthalmology"},{"issue":"3","key":"3590_CR2","doi-asserted-by":"publisher","first-page":"686","DOI":"10.4103\/IJO.IJO_379_23","volume":"71","author":"P Rewri","year":"2023","unstructured":"Rewri P (2023) Towards better management of glaucoma in India. Ind J Ophthalmol 71(3):686","journal-title":"Ind J Ophthalmol"},{"issue":"6","key":"3590_CR3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1097\/IJG.0b013e3181c4ac5b","volume":"19","author":"R George","year":"2010","unstructured":"George R, Ve RS, Vijaya L (2010) Glaucoma in India: estimated burden of disease. J Glaucoma 19(6):391\u2013397","journal-title":"J Glaucoma"},{"issue":"9","key":"3590_CR4","doi-asserted-by":"publisher","first-page":"e888","DOI":"10.1016\/S2214-109X(17)30293-0","volume":"5","author":"RRA Bourne","year":"2017","unstructured":"Bourne RRA, Flaxman SR, Braithwaite T, Cicinelli MV, Das A, Jonas JB et al (2017) Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis. Lancet Glob Health 5(9):e888\u2013e897","journal-title":"Lancet Glob Health"},{"issue":"3","key":"3590_CR5","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/bjo.2005.081224","volume":"90","author":"HA Quigley","year":"2006","unstructured":"Quigley HA (2006) The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 90(3):262\u2013267","journal-title":"Br J Ophthalmol"},{"key":"3590_CR6","doi-asserted-by":"publisher","unstructured":"The advanced glaucoma intervention study (AGIS) (2000) The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 130(4):429\u2013440. https:\/\/doi.org\/10.1016\/S0002-9394(00)00538-9","DOI":"10.1016\/S0002-9394(00)00538-9"},{"key":"3590_CR7","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1016\/S0161-6420(01)00873-9","volume":"108","author":"PR Lichter","year":"2001","unstructured":"Lichter PR, Musch DC, Gillespie BW et al (2001) Interim clinical outcomes in the collaborative initial glaucoma treatment study comparing initial treatment randomized to medications or surgery. Ophthalmology 108:1943\u20131953","journal-title":"Ophthalmology"},{"issue":"1","key":"3590_CR8","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1001\/archopht.121.1.48","volume":"121","author":"MC Leske","year":"2003","unstructured":"Leske MC (2003) Factors for glaucoma progression and the effect of treatment. Arch Ophthalmol 121(1):48","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"3590_CR9","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1016\/j.ophtha.2011.01.047","volume":"118","author":"DC Musch","year":"2011","unstructured":"Musch DC, Gillespie BW, Niziol LM, Lichter PR, Varma R (2011) Intraocular pressure control and long-term visual field loss in the collaborative initial glaucoma treatment study. Ophthalmology 118(9):1766\u20131773","journal-title":"Ophthalmology"},{"issue":"1","key":"3590_CR10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.2174\/1874364101004010052","volume":"4","author":"M Goel","year":"2010","unstructured":"Goel M (2010) Aqueous humor dynamics: a review. Open Ophthalmol J 4(1):52\u201359","journal-title":"Open Ophthalmol J"},{"issue":"2","key":"3590_CR11","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2147\/tcrm.2006.2.2.193","volume":"2","author":"RJ Noecker","year":"2006","unstructured":"Noecker RJ (2006) The management of glaucoma and intraocular hypertension: current approaches and recent advances. Ther Clin Risk Manag 2(2):193\u2013205. https:\/\/doi.org\/10.2147\/tcrm.2006.2.2.193","journal-title":"Ther Clin Risk Manag"},{"key":"3590_CR12","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2147\/JEP.S259297","volume":"13","author":"G Al-Humimat","year":"2021","unstructured":"Al-Humimat G, Marashdeh I, Daradkeh D, Kooner K (2021) Investigational rho kinase inhibitors for the treatment of glaucoma. J Exp Pharmacol 13:197\u2013212","journal-title":"J Exp Pharmacol"},{"issue":"2","key":"3590_CR13","doi-asserted-by":"publisher","first-page":"e483","DOI":"10.1038\/cddis.2013.10","volume":"4","author":"J Shi","year":"2013","unstructured":"Shi J, Wu X, Surma M, Vemula S, Zhang L, Yang Y et al (2013) Distinct roles for ROCK1 and ROCK2 in the regulation of cell detachment. Cell Death Dis 4(2):e483\u2013e493","journal-title":"Cell Death Dis"},{"key":"3590_CR14","doi-asserted-by":"crossref","unstructured":"Nourinia R, Nakao S, Zandi S, Safi S, Hafezi-Moghadam A, Ahmadieh H (2017) ROCK inhibitors for the treatment of ocular diseases. British J Ophthalmol","DOI":"10.1136\/bjophthalmol-2017-310378"},{"key":"3590_CR15","unstructured":"Central Drugs Standard Control Organization Ministry of Health & Family Welfare [Internet] Government of India. List of new drugs approved (2019)"},{"key":"3590_CR16","unstructured":"Central Drugs Standard Control Organization Ministry of Health & Family Welfare [Internet] Government of India. List of new drugs approved in 2020"},{"key":"3590_CR17","unstructured":"Hodapp E, Parrish RK, Anderson DR (1993) Clinical Decisions in Glaucoma [Internet]. Google Books. Mosby"},{"issue":"1","key":"3590_CR18","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1755-3768.1975.tb01135.x","volume":"53","author":"N Ehlers","year":"2009","unstructured":"Ehlers N, Bramsen T, Sperling S (2009) Applanation tonometry and central corneal thickness. Acta Ophthalmol 53(1):34\u201343","journal-title":"Acta Ophthalmol"},{"key":"3590_CR19","doi-asserted-by":"publisher","first-page":"4367","DOI":"10.2147\/OPTH.S337105","volume":"15","author":"NC Villegas","year":"2021","unstructured":"Villegas NC, Lee WS (2021) Effectiveness of netarsudil as an additional therapy for glaucoma in patients already on maximally tolerated medical therapy. Clin Ophthalmol 15:4367\u20134372","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"3590_CR20","first-page":"101","volume":"7","author":"M Moshirfar","year":"2018","unstructured":"Moshirfar M, Parker L, Birdsong OC, Ronquillo YC, Hofstedt D, Shah TJ et al (2018) Use of rho kinase inhibitors in ophthalmology: a review of the literature. Med Hypothesis Discov Innov Ophthalmol 7(3):101\u2013111","journal-title":"Med Hypothesis Discov Innov Ophthalmol"},{"issue":"11","key":"3590_CR21","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.18203\/2319-2003.ijbcp20184263","volume":"7","author":"RR Ghanghas","year":"2018","unstructured":"Ghanghas RR, Mohan P, Sharma V, Sharma AK (2018) Netarsudil: a novel intra-ocular pressure lowering agent. Int J Basic Clin Pharmacol 7(11):2268\u20132270","journal-title":"Int J Basic Clin Pharmacol"},{"key":"3590_CR22","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.ajo.2019.06.016","volume":"207","author":"S Asrani","year":"2019","unstructured":"Asrani S, Robin AL, Serle JB, Lewis RA, Usner DW, Kopczynski CC et al (2019) Netarsudil\/Latanoprost fixed-dose combination for elevated intraocular pressure: three-month data from a randomized phase 3 trial. Am J Ophthalmol 207:248\u2013257","journal-title":"Am J Ophthalmol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-025-03590-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-025-03590-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-025-03590-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T18:03:37Z","timestamp":1766167417000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-025-03590-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,12]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3590"],"URL":"https:\/\/doi.org\/10.1007\/s10792-025-03590-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4859451\/v1","asserted-by":"object"}]},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,12]]},"assertion":[{"value":"5 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the institutional ethics committee (HIMSR\/IEC\/0067\/2022 dated 22.11.2022). All procedures followed were in accordance with the principles of the 1964 Helsinki Declaration and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"240"}}